ANSM Safety Recall: Autoimmunity IDS SS-A/Ro Reagent
Summary
The French ANSM has issued a safety recall (R2532493) for a specific lot of the Autoimmunity IDS SS-A/Ro reagent manufactured by Immunodiagnostic Systems (IDS). Laboratories using this reagent have been notified directly by the manufacturer.
What changed
The French National Agency for Medicines and Health Products Safety (ANSM) has announced a safety recall, registered under number R2532493, concerning a specific lot of the Autoimmunity IDS SS-A/Ro reagent from Immunodiagnostic Systems (IDS). This action is a product recall, indicating a potential safety issue or defect with the reagent.
Laboratories that have received the affected reagent lot must take immediate action as directed by Immunodiagnostic Systems (IDS). While the ANSM directs inquiries to the manufacturer, affected entities should consult the provided letter from IDS dated March 17, 2026, for specific instructions on handling the recalled product, which may include returning or discarding the reagent. Failure to comply with recall procedures could have implications for patient safety and laboratory accreditation.
What to do next
- Review correspondence from Immunodiagnostic Systems (IDS) regarding recall R2532493.
- Implement necessary actions for the affected lot of Autoimmunity IDS SS-A/Ro reagent as instructed by IDS.
- Contact Immunodiagnostic Systems (IDS) directly for any questions or clarification.
Archived snapshot
Mar 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Information de rappel n° R2532493 destinée aux laboratoires d'analyses de biologie médicale L'ANSM a été informée de la mise en œuvre du retrait d’un lot effectué par la société Immunodiagnostic Systems (IDS).
Les utilisateurs concernés ont reçu le courrier ci-joint.
Cette action de sécurité est enregistrée à l’ANSM sous le n° R2532493.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Immunodiagnostic Systems (IDS) (17/03/2026)
Related changes
Get daily alerts for ANSM Drug & Device Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from ANSM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.